Related Experiment Video
Updated: May 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus
Patricia Peñacoba Toribio1, María Emilia Córica Albani2, Mercedes Mayos Pérez3
1Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
Abstract:
Shrinking lung syndrome (SLS) is a rare manifestation of systemic lupus erythematosus. We report the case of a patient with non-responding SLS (neither to glucocorticoids nor immunosupresors), who showed remarkable improvement after the onset of treatment with rituximab. Although there is a little evidence, treatment with rituximab could be proposed in SLS when classical treatment fails.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents